Evidence map›Paper›PMID 27081512›Full record

ArticleHuman genome variation2014

A novel PTCH1 mutation in a patient with Gorlin syndrome.

Nana Okamoto, Takuya Naruto, Tomohiro Kohmoto, Takahide Komori, Issei Imoto

Open access · goldAbstract read
In one paragraph

Article in Human genome variation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Detection ofBiomedicines · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Molecular diagnosis of an infant withHuman genome variation · 2020
    Article
  6. Novel compound heterozygousHuman genome variation · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. A novel truncating mutation of PTCH1 in a Chinese family with Gorlin syndrome.International journal of clinical and experimental pathology · 2017
    Article
  11. NovelHuman genome variation · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nana OkamotoDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine , Kobe, Japan.
Takuya NarutoDepartment of Stress Science, Institute of Health Biosciences, The University of Tokushima Graduate School , Tokushima, Japan.
Tomohiro KohmotoStudent Lab, Faculty of Medicine, The University of Tokushima , Tokushima, Japan.
Takahide KomoriDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine , Kobe, Japan.
Issei ImotoDepartment of Human Genetics, Institute of Health Biosciences, The University of Tokushima Graduate School , Tokushima, Japan.
Tokushima University · JPKobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gorlin syndrome is an autosomal dominant disorder characterized by a wide range of developmental abnormalities and a predisposition to various tumors, and it is linked to the alteration of several causative genes, including PTCH1. We performed targeted resequencing using a next-generation sequencer to analyze genes associated with known clinical phenotypes in an 11-year-old male with sporadic jaw keratocysts. A novel duplication mutation (c.426dup) in PTCH1, resulting in a truncated protein, was identified.

Identifiers

PMID27081512
PMCPMC4785514
OpenAlexW2316494531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.